Phylonix Pharmaceuticals Inc

100 Inman Street,
Suite 300,
Cambridge,
MA 02139
United States of America
Tel: (617) 441-6700
Fax: (617) 441-6766

Print Email to a friend

Phylonix is a Contract Research Organization providing in vivo zebrafish assays for drug discovery and screening. Our toxicologists, biochemists, developmental biologists, aquaculturists and molecular biologists can perform general, organ and cell specific toxicity studies, pathology, gene profiling, cellular activity and behavioral studies. Custom assays can be designed for high throughput quantitative microplate analysis or multi-parameter visual assessment.

Further Information: http://www.phylonix.com



Related news from our archive

NIH Grants Phylonix Phase II SBIR to Develop High-Throughput In vivo Zebrafish Assays
Phylonix has been awarded a $1,250,369 Phase II Small Business Innovation for assessing Cytochrome P450 drug metabolism and safety.

EPA Selects Phylonix to Screen Compound Library in Zebrafish
Phylonix will profile biological toxins by using zebrafish test system under a two-year contract with $4.3 million award under the agency’s ToxCast™ project.